Department of Microbiology, Al-Amiri Hospital, Kuwait, Kuwait.
Department of Microbiology, College of Medicine, Kuwait University, Kuwait, Kuwait.
Med Princ Pract. 2022;31(6):562-569. doi: 10.1159/000527640. Epub 2022 Oct 29.
The aim of this study was to determine the bacterial profile and prevalence of antibiotic resistance patterns of uropathogens, as well as to evaluate the problem with extended-spectrum β-lactamases (ESBLs)-producing isolates, causing urinary tract infections (UTIs) in children in Al-Amiri Hospital, Kuwait, over a 5-year period.
Significant isolates from symptomatic pediatric patients with UTIs from January 2017 to December 2021 were identified by conventional methods and by the VITEK 2 identification card system. Antimicrobial susceptibility testing was performed by the disk diffusion method for Gram-positive organisms and an automated VITEK 2 system for Gram-negative organisms. ESBL-producing Enterobacterales were detected by the double-disk diffusion method and VITEK 2 system.
Significant bacteriuria was detected in 13.7% of the 9,742 urine samples. Escherichia coli accounted for 67.3% of these, followed by Klebsiella pneumoniae (8.9%), Proteus spp. (5.7%), and Enterococcus spp. (7.4%), respectively. High resistance rates were observed among the Enterobacterales against ampicillin, cephalothin, nitrofurantoin, amoxicillin/clavulanic acid, and trimethoprim-sulfamethoxazole. The prevalence of ESBL-producing E. coli and K. pneumoniae was 26% and 55%, respectively. The most sensitive among the antibiotics tested for Gram-negative organisms were meropenem, amikacin, gentamicin, and piperacillin/tazobactam, while the antibiotics tested for Gram-positive organisms were vancomycin, ampicillin, linezolid, and nitrofurantoin.
E. coli remains the most common uropathogen. A high percentage of uropathogens causing UTI in children were highly resistant to the first- and second-line antibiotics for the therapy of UTI. ESBL-producing bacteria were highly prevalent in children in our hospital. Local antibiograms should be used to assist with empirical UTI treatment.
本研究旨在确定导致科威特 Al-Amiri 医院儿童尿路感染(UTI)的尿病原体的细菌谱和抗生素耐药模式的流行情况,并评估产超广谱β-内酰胺酶(ESBL)的分离株的问题。
采用常规方法和 VITEK 2 鉴定卡系统对 2017 年 1 月至 2021 年 12 月期间患有 UTI 的有症状儿科患者的有意义分离株进行鉴定。采用纸片扩散法对革兰氏阳性菌进行抗菌药敏试验,采用自动 VITEK 2 系统对革兰氏阴性菌进行抗菌药敏试验。采用双纸片扩散法和 VITEK 2 系统检测产 ESBL 的肠杆菌科。
在 9742 份尿样中,有 13.7%的尿样检测出有显著的菌尿症。其中大肠埃希菌占 67.3%,其次是肺炎克雷伯菌(8.9%)、变形杆菌属(5.7%)和肠球菌属(7.4%)。肠杆菌科对氨苄西林、头孢噻吩、呋喃妥因、阿莫西林/克拉维酸和复方磺胺甲噁唑的耐药率较高。产 ESBL 的大肠埃希菌和肺炎克雷伯菌的流行率分别为 26%和 55%。在革兰氏阴性菌中,对测试的抗生素中最敏感的是美罗培南、阿米卡星、庆大霉素和哌拉西林/他唑巴坦,而在革兰氏阳性菌中,最敏感的抗生素是万古霉素、氨苄西林、利奈唑胺和呋喃妥因。
大肠埃希菌仍然是最常见的尿病原体。导致儿童 UTI 的尿病原体对治疗 UTI 的一线和二线抗生素有很高的耐药性。我院儿童中 ESBL 产生菌的流行率很高。应使用当地药敏谱来协助经验性 UTI 治疗。